ICAHN School of Medicine At Mount Sinai
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1963-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.mssm.edu
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness
Completed
- Conditions
- Ulcerative ColitisInflammatory Bowel DiseaseCrohn's Disease
- First Posted Date
- 2015-04-22
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 50
- Registration Number
- NCT02423512
- Locations
- 🇺🇸
Susan and Leonard Feinstein Inflammatory Bowel Disease Center, New York, New York, United States
Self-injection and Self-management
Not Applicable
Completed
- Conditions
- Food Allergy
- Interventions
- Behavioral: Simulation of epinephrine self-injection
- First Posted Date
- 2015-04-15
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 60
- Registration Number
- NCT02417493
- Locations
- 🇺🇸
Jaffe Food Allergy Institute, New York, New York, United States
Treatment of Actinic Keratoses (AK) on the Face
Phase 1
Completed
- Conditions
- Actinic Keratoses
- Interventions
- Drug: ingenol mebutate 0.015%Other: dermasil lotion
- First Posted Date
- 2015-04-08
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 20
- Registration Number
- NCT02411851
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Use of Pre-Emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery
Not Applicable
Withdrawn
- Conditions
- Pelvic Organ Prolapse
- Interventions
- Drug: pudendal block
- First Posted Date
- 2015-04-06
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Registration Number
- NCT02409498
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
STRIPES Study: Study To Reduce Infection Post cEsarean Section
Not Applicable
Completed
- Conditions
- Chlorhexidine Gluconate ClothsEndometritisInfectious MorbiditySurgical Site InfectionsInfection; Cesarean Section
- Interventions
- Device: 2% chlorhexidine gluconate (CHG) clothDevice: Placebo cloth
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2020-11-09
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 1356
- Registration Number
- NCT02402907
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Battlefield Acupuncture for the Treatment of Low Back Pain in the Emergency Department
Phase 1
Completed
- Conditions
- Low Back Pain
- Interventions
- Other: Battlefield Acupuncture
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 30
- Registration Number
- NCT02399969
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Smartphone Technology and CBT-GSH in Binge Eaters
Phase 1
Completed
- Conditions
- Bulimia NervosaBinge Eating Disorder
- Interventions
- Other: CBT-GSHOther: Noom Monitor
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 66
- Registration Number
- NCT02399982
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
Phase 2
Completed
- Conditions
- Posttraumatic Stress Disorder (PTSD)
- Interventions
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 30
- Registration Number
- NCT02397889
- Locations
- 🇺🇸
Depression and Anxiety Center (DAC), New York, New York, United States
Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients
Not Applicable
Completed
- Conditions
- Food Allergy
- Interventions
- Other: Partially Hydrolyzed Whey formula
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 10
- Registration Number
- NCT02397876
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Not Applicable
Completed
- Conditions
- StrokeAortic StenosisCerebrovascular AccidentBrain Infarction
- Interventions
- Device: Embol-X Embolic Protection DeviceDevice: CardioGard Cannula
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 383
- Registration Number
- NCT02389894
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
🇺🇸Montefiore Einstein Heart Center, Bronx, New York, United States
© Copyright 2025. All Rights Reserved by MedPath